Jane Street Group, LLC Caladrius Biosciences, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.41 - $0.74 $203 - $367	497 Added 2.98%	17,156 $9,000
Q1 2022 May 17, 2022	SELL	$0.63 - $1.03 $3,292 - $5,382	-5,226 Reduced 23.88%	16,659 $12,000
Q4 2021 Feb 15, 2022	BUY	$0.83 - $1.22 $18,164 - $26,699	21,885 New	21,885 $18,000
Q3 2020 Nov 17, 2020	SELL	$1.6 - $3.0 $17,256 - $32,355	-10,785 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.66 - $2.38 $17,903 - $25,668	10,785 New	10,785 $19,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.